illumina grail
Global Antitrust: EC Flags Illumina for Proceeding With Purchase of Cancer Test Company Despite Investigation
The European Commission is investigating whether Illumina’s decision to complete its acquisition of cancer test manufacturer Grail — despite the Commission’s ongoing investigation into any anticompetitive effects of the deal — breaches the “standstill obligation” under Article 7…
FTC Sues to Block Illumina/Grail Deal
The Federal Trade Commission has filed an administrative complaint and authorized a federal court lawsuit to block Illumina’s $7.1 billion proposed acquisition of Grail —…